Abstract
Epidermal growth factor (EGF), a small polypeptide of 53 amino acid residues and a molecular mass of approximately 6000 daltons, was identified and isolated nearly 25 years ago (Cohen 1962) and is presently the best characterized epithelial cell mitogen. Although a great deal is known about the structure of both EGF and its receptor, including the primary sequences, several important questions remain unanswered. First, what is the physiological function of EGF? Does it play a role in epithelial cell renewal, which in the human body requires a constantly high rate of cell proliferation (approximately 4×106 cell divisions per second)? Second, by what mechanism does EGF induce cell proliferation? Third, does EGF play a role in the induction and/or maintenance of malignant transformation? The discoveries that many types of malignant cells produce EGF-related proteins (transforming growth factor-α; TGF-α) which have the capacity to induce certain transformed phenotypes (see Derynck, this Vol.) and that molecules related to the EGF receptor can function as oncogenes (v-erbB, neu) suggest that parts of the EGF mechanism may have a role in oncogenesis. The importance of understanding this role is underscored by the fact that over 90% of all malignancies arise from epithelial cells (Wright and Alison 1984). This review addresses various aspects of the first two questions. These issues are discussed further in the articles which follow by Derynck, by Schlessinger and by Beug et al.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baird A, Mormede P, Ying S-Y, Wehrenberg WB, Ueno N, Ling N, Guillemin R (1985) A nonmitogenic pituitary function of fibroblast growth factor: regulation of thyrotropin and prolactin secretion. Proc Natl Acad Sci USA 82:5545–5549
Beguinot L, Lyall RM, Willingham MC, Pastan I (1984) Down-regulation of the epidermal growth factor receptor in KB cells is due to receptor internalization and subsequent degradation in lysosomes. Proc Natl Acad Sci USA 81:2384–2388
Beneviste R, Speeg KV, Carpenter G, Cohen S, Lindner J, Rabinowitz D (1978) Epidermal growth factor stimulates secretion of human chorionic gonadotropin by cultured human choriocarcinoma cells. J Clin Endocrinol Metab 46:169–172
Bower JM, Camble R, Gregory H, Gerring EL, Wiltshire IR (1975) The inhibition of gastric acid secretion by epidermal growth factor. Experientia 31:825–826
Carpenter G, Cohen S (1976) 125I-labeled human epidermal growth factor (hEGF): binding, internalization, and degradation in human fibroblasts. J Cell Biol 71:159–171
Carpenter G, Zendegui J (1986) A biological assay for epidermal growth factor/urogastrone and related polypeptides. Anal Biochem 153: in press
Cohen S (1962) Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new–born animal. J Biol Chem 237:1555–1562
Cohen S, Elliott GA (1963) The stimulation of epidermal keratinization by a protein isolated from the submaxillary gland of the mouse. J Invest Dermato140:1–5
Decker SJ (1984) Aspects of the metabolism of the epidermal growth factor receptor in A431 human epidermoid carcinoma cells. Mol Cell Biol 4:571–575
Dunn WA, Connolly TP, Hubbard AL (1986) Receptor–mediated endocytosis of epidermal growth factor by rat hepatocytes: receptor pathway. J Cell Biol 102:24–36
Kawamoto T, Sato JD, Le A, Polikoff J, Sato GH, Mendelsohn J (1983) Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci USA 80:1337–1341
Mattila A-L, Perheentupa J, Pesonen K, Viinikka L (1985) Epidermal growth factor in human urine from birth to puberty. J Clin Endocrinol Metab 61:997–1000
Moore GPM, Panaretto BA, Carter NB (1985) Epidermal hyperplasia and wool follicle regression in sheep infused with epidermal growth factor. J Invest Dermatol 84:172–175
Partanen A-M, Ekblom P, Thesleff I (1985) Epidermal growth factor inhibits morphogenesis and cell differentiation in cultured mouse embryonic teeth. Dev Biol 111:84–94
Schonbrunn A, Krasnoff M, Westendorf JM, Tashjian AH (1980) Epidermal growth factor and thyrotropin-releasing hormone act similarly on a clonal pituitary cell strain. Modulation of hormone production and inhibition of cell proliferation. J Cell Biol 85:786–797
Seppa H, Grotendorst G, Seppa S, Schiffman E, Martin GR (1982) Platelet–derived growth factor is chemotactic for fibroblasts. J Cell Biol 92:584–588
Stoscheck CM, Carpenter G (1984) Down regulation of epidermal growth factor receptors: direct demonstration of receptor degradation in human fibroblasts. J Cell Biol 98:1048–1053
Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA, Shepard HM (1985) Recombinant human tumor necrosis factor–a: effects on proliferation of normal and transformed cells in vitro. Science 230:943–945
Sundell HW, Gray ME, Serenius FS, Escobedo MB, Stahlman MT (1980) Effects of epidermal growth factor on lung maturation in fetal lambs. Am J Pathol 100:707–726
Tucker RF, Shipley GD, Moses HL, Holley RW (1984) Growth inhibitor from BSC-1 cells closely related to platelet type B transforming growth factor. Science 226:705–707
Wright N, Alison M (1984) The biology of epithelial cell populations, vol 1. Oxford Univ Press, Oxford, p 3
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Carpenter, G., Goodman, L., Shaver, L. (1986). The Physiology of Epidermal Growth Factor. In: Kahn, P., Graf, T. (eds) Oncogenes and Growth Control. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73325-3_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-73325-3_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-18760-8
Online ISBN: 978-3-642-73325-3
eBook Packages: Springer Book Archive